Nutritional supplementation with polymeric diet enriched with transforming growth factor-beta 2 for children with Crohn's disease

Israel Medical Association Journal

Volumn 10, Issue 7, 2008, Pages 503-507

  Hartman, Corina ^a,h   Berkowitz, Drora ^b,i   Weiss, Batia ^c,h   Shaoul, Ron ^d,i   Levine, Arie ^e,h   Adiv, Orly Eshach ^b,i   Shapira, Riki ^a,h   Fradkin, Akiva ^c   Wilschanski, Michael ^f   Tamir, Ada ^g   Shamir, Raanan ^a,h  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b MEYER CHILDREN S HOSPITAL   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d BNAI ZION MEDICAL CENTER   (Israel)

^e WOLFSON MEDICAL CENTER   (Israel)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^g CLALIT HEALTH SERVICES   (Israel)

^h TEL AVIV UNIVERSITY   (Israel)

ⁱ TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Children; Crohn's disease; Nutritional therapy; Transforming growth factor beta

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA2;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HOSPITAL DEPARTMENT; HUMAN; ISRAEL; MALE; MEDICAL RECORD REVIEW; PEDIATRIC HOSPITAL; POLYMERIC DIET; RETROSPECTIVE STUDY; ANTHROPOMETRY; DIET; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REMISSION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTHROPOMETRY; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; DIET; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA2; TREATMENT OUTCOME;

EID: 52049087901     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 2003;88:995-1000.
2. Kim SC, Ferry GD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 2004;126:1550-60.
3. Kleinman RE, Baldassano RN, Caplan A, et al. Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004;39:15-27.
4. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001:CD000542.
5. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996;38:543-8.
6. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988;94:603-10.
7. Seidman E, Jones A, Issenman R, Griffiths A. Relapse prevention/growth enhancement in pediatric Crohn's disease: multicenter randomized controlled trial of intermittent enteral nutrition versus alternative day prednisolone [Abstract]. J Pediatr Gastroenterol Nutr 1996;23:344.
8. Verma S, Kirkwood B, Brown S, Giaffer MH. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Dig Liver Dis 2000;32:769-74.
9. Bannerjee K, Camacho-Hubner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-5.
10. Breese EJ, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 1995;9:547-52.
11. Gassull MA, Fernandez-Banares F, Cabre E, et al., for the Eurpoean Group on Enteral Nutrition in Crohn's Disease. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002;51:164-8.
12. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000;30:78-84.
13. Schmidt-Weber CB, Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 2004;16:709-16.
14. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994;8:609-15.
15. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000;14:281-9.
16. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, et al. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 2004;20:167-72.
17. Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Pediatr Gastroenterol Nutr 1992;14:216-22.
18. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000;31:8-15.
19. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001;96:822-8.
20. Hahm KB, Im YH, Parks TW, et al. Loss of transforming growth factor beta signaling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001;49:190-8.
21. Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001;108:601-9.